Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
20.6%
% of XLV's 64 holdings also in HART
17.8%
% of HART's 83 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus HART)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in HART |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.2% | 6.1% | 6.1% |
|
JOHNSON & JOHNSON | 6.9% | 5.0% | 5.0% |
|
UNITEDHEALTH GROUP INC | 9.0% | 4.2% | 4.2% |
|
ABBOTT LABORATORIES | 3.6% | 5.4% | 3.6% |
|
PFIZER INC | 2.9% | 4.1% | 2.9% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to HART
|
MERCK & CO. INC. | 6.2% |
|
ABBVIE INC | 5.7% |
|
ELI LILLY & CO | 5.1% |
|
UNITEDHEALTH GROUP INC | 4.8% |
|
THERMO FISHER SCIENTIFIC INC | 4.1% |
|
DANAHER CORP | 3.0% |
|
AMGEN INC | 2.8% |
|
INTUITIVE SURGICAL INC | 2.5% |
|
STRYKER CORP | 2.1% |
|
CIGNA CORPORATION | 2.0% |
XLV Underweight Relative to HART
 |
NOVO NORDISK A/S-B | -5.5% |
 |
NOVARTIS AG | -4.9% |
|
ALPHABET INC. CLASS A | -4.7% |
 |
ASTRAZENECA PLC | -4.6% |
|
APPLE INC | -4.4% |
|
NIKE INC -CL B | -4.4% |
 |
SANOFI-AVENTIS | -2.7% |
|
ABBOTT LABORATORIES | -1.8% |
|
PFIZER INC | -1.2% |
|
CYTOKINETICS INC | -1.1% |